Loss of IFN gamma receptor is an independent prognostic factor in ovarian cancer. | Clin Cancer Res;13(14): 4139-45, 2007 Jul 15. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Loss of IFN gamma receptor is an independent prognostic factor in ovarian cancer.

Duncan, Timothy J; Rolland, Phil; Deen, Suha; Scott, Ian V; Liu, David T Y; Spendlove, Ian; Durrant, Lindy G.

Affiliation

Duncan TJ; Academic and Clinical Department of Oncology, University of Nottingham, Nottingham, UK.

Clin Cancer Res ; 13(14): 4139-45, 2007 Jul 15.

Article in En | MEDLINE | ID: mdl-17634541

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Receptors, Interferon Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2007 Document type: Article Affiliation country:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Receptors, Interferon Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2007 Document type: Article Affiliation country: